These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 11842317

  • 1. Therapeutic significance of distal airway inflammation in asthma.
    Martin RJ.
    J Allergy Clin Immunol; 2002 Feb; 109(2 Suppl):S447-60. PubMed ID: 11842317
    [Abstract] [Full Text] [Related]

  • 2. Small airway asthma therapy, challenges, and the future.
    Casale TB.
    Postgrad Med; 2003 Feb; 113(2 Suppl):15-20. PubMed ID: 19667625
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma.
    Corren J, Tashkin DP.
    Clin Ther; 2003 Mar; 25(3):776-98. PubMed ID: 12852702
    [Abstract] [Full Text] [Related]

  • 4. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients.
    Corren J, Nelson H, Greos LS, Bensch G, Goldstein M, Wu J, Wang S, Newman K.
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):405-11. PubMed ID: 11730183
    [Abstract] [Full Text] [Related]

  • 5. Flunisolide HFA for the treatment of asthma: an old friend reformulated.
    Shafazand S, Colice G.
    Expert Opin Pharmacother; 2004 May; 5(5):1163-73. PubMed ID: 15155115
    [Abstract] [Full Text] [Related]

  • 6. Flunisolide HFA.
    Waugh J, Goa KL.
    Am J Respir Med; 2002 May; 1(5):369-72; discussion 373. PubMed ID: 14720039
    [Abstract] [Full Text] [Related]

  • 7. Effect of HFA-flunisolide on peripheral lung inflammation in asthma.
    Hauber HP, Gotfried M, Newman K, Danda R, Servi RJ, Christodoulopoulos P, Hamid Q.
    J Allergy Clin Immunol; 2003 Jul; 112(1):58-63. PubMed ID: 12847480
    [Abstract] [Full Text] [Related]

  • 8. Flunisolide hydrofluoroalkane with integrated spacer for treating asthma: an updated review.
    Berger WE, Tashkin DP.
    Allergy Asthma Proc; 2015 Jul; 36(2):105-15. PubMed ID: 25635610
    [Abstract] [Full Text] [Related]

  • 9. Part III: Location of asthma inflammation and the distal airways: clinical implications.
    Kraft M.
    Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S21-7. PubMed ID: 17925065
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
    Vanden Burgt JA, Busse WW, Martin RJ, Szefler SJ, Donnell D.
    J Allergy Clin Immunol; 2000 Dec; 106(6):1209-26. PubMed ID: 11112914
    [Abstract] [Full Text] [Related]

  • 11. Hydrofluoroalkane formulations of inhaled corticosteroids for the treatment of asthma.
    Zeidler M, Corren J.
    Treat Respir Med; 2004 Dec; 3(1):35-44. PubMed ID: 15174892
    [Abstract] [Full Text] [Related]

  • 12. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
    Davies RJ, Stampone P, O'Connor BJ.
    Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
    [Abstract] [Full Text] [Related]

  • 13. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
    Barnes N, Price D, Colice G, Chisholm A, Dorinsky P, Hillyer EV, Burden A, Lee AJ, Martin RJ, Roche N, von Ziegenweidt J, Israel E.
    Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
    [Abstract] [Full Text] [Related]

  • 14. Improved delivery of inhaled steroids to the large and small airways.
    Leach CL.
    Respir Med; 1998 Jun; 92 Suppl A():3-8. PubMed ID: 9850357
    [Abstract] [Full Text] [Related]

  • 15. The role of small airway inflammation in asthma.
    Tashkin DP.
    Allergy Asthma Proc; 2002 Jun; 23(4):233-42. PubMed ID: 12221892
    [Abstract] [Full Text] [Related]

  • 16. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study.
    Ederle K, Multicentre Study Group.
    Eur Rev Med Pharmacol Sci; 2003 Jun; 7(2):45-55. PubMed ID: 12911119
    [Abstract] [Full Text] [Related]

  • 17. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants.
    Richards J, Hirst P, Pitcairn G, Mahashabde S, Abramowitz W, Nolting A, Newman SP.
    J Aerosol Med; 2001 Jun; 14(2):197-208. PubMed ID: 11681651
    [Abstract] [Full Text] [Related]

  • 18. Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma.
    Thongngarm T, Silkoff PE, Kossack WS, Nelson HS.
    J Asthma; 2005 May; 42(4):257-63. PubMed ID: 16032934
    [Abstract] [Full Text] [Related]

  • 19. Flunisolide for the treatment of asthma.
    Melani AS.
    Expert Rev Clin Pharmacol; 2014 May; 7(3):251-8. PubMed ID: 24716719
    [Abstract] [Full Text] [Related]

  • 20. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
    Micheletto C, Guerriero M, Tognella S, Dal Negro RW.
    Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.